NCT01437189View on ClinicalTrials.gov

The Effects of Sertraline on Depression in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 1, 2011

Primary Completion Date

August 1, 2013

Study Completion Date

November 1, 2013

Conditions
DepressionParkinson's Disease
Interventions
DRUG

Sertraline

Starting dose 25mg/day for 1 week, then increasing to 50mg/day, add on 50mg each time when the depressive symptoms are not improved, at 2-week intervals. Maximum: 200mg/day. Maintenance: lowest effective dose.

Trial Locations (1)

310009

Department of Neurology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT01437189 - The Effects of Sertraline on Depression in Parkinson's Disease | Biotech Hunter | Biotech Hunter